Since the 1970s, the epidemic of hepatocellular carcinoma (HCC) has spread beyond the
Eastern Asian predominance and has been increasing in Northern hemisphere, especially …

Worldwide, hepatitis B virus (HBV) accounts for an estimated 370 million chronic infections,
hepatitis C virus (HCV) for an estimated 130 million, and HIV for an estimated 40 million. In …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

Objective: The objective of this study is to estimate life expectancies of HIV-positive patients
conditional on response to antiretroviral therapy (ART). Methods: Patients aged more than …

These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …

Background An increasing proportion of deaths among human immunodeficiency virus (HIV)–
infected persons with access to combination antiretroviral therapy (cART) are due to …

Serologic testing for hepatitis B surface antigen (HBsAg) is the primary way to identify
persons with chronic hepatitis B virus (HBV) infection. Testing has been recommended …

Globally, in 2017 35 million people were living with HIV (PLHIV) and 257 million had chronic
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …

Chronic HBV infection is an important public health problem worldwide and in the United
States. A treatment algorithm for the management of this disease, published previously by a …

Persons at high risk for human immunodeficiency virus (HIV) infection are also likely to be at
risk for other infectious pathogens, including hepatitis B virus (HBV) or hepatitis C virus …